{"count":4,"index":{"built_at":"2026-07-26T21:20:11.659029+00:00","public_records":55311,"revision":"cdf8ff7bb577794eceb61800"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Myths vs facts: CYP1A2 and longevity"},"results":[{"answer":"The claim that CYP1A2 variants directly affect longevity is not well supported by current evidence. CYP1A2 primarily influences caffeine metabolism. Some observational studies suggest a link between caffeine intake and reduced risk of certain diseases, but effect sizes are small and confounded by lifestyle. Most associations come from GWAS or epidemiological data, not from interventional trials. Consumer DNA tests (e.g., MyBody-X) report SNPs like rs762551, but their predictive value for lifespan is negligible. No robust evidence shows that CYP1A2 genotype alone significantly impacts longevity. Diet, exercise, and smoking are far more influential. Therefore, labeling a CYP1A2 variant as a 'longevity marker' is more myth than fact. The evidence is unclear and largely mechanistic, not clinically validated.","area":"gesundheit","canonical_id":"gesundheit:canonical-89d6f16f3b5834c0877eba3d","id":"public-3a0ef405ec9980a360c4ab97","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP1A2 and longevity","score":30.55883937,"snippet":"The claim that CYP1A2 variants directly affect longevity is not well supported by current evidence. CYP1A2 primarily influences caffeine metabolism. Some observational studies suggest a link between caffeine intake and reduced risk of certain diseases, but effect sizes are small and confounded by lifestyle. Most associations come from GWAS or epidemiological data, not from interventional trials. Consumer DNA tests (e.g., MyBody-X) report SNPs like rs762551, but their predictive value for lifespan is negligible. No robust evidence shows that CYP1A2 genotype alone significantly impacts longevity. Diet, exercise, and smoking are far more influential. Therefore, labeling a CYP1A2 variant as a 'l","sources":[],"title":"Myths vs facts: CYP1A2 and longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3a0ef405ec9980a360c4ab97/myths-vs-facts-cyp1a2-and-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 ist ein Gen, das den Koffeinabbau in der Leber steuert. Der Mythos besagt, dass die Genvariante bestimmt, ob Kaffee die Lebenserwartung verlängert oder verkürzt. Die Fakten: Es gibt tatsächlich Studien, die zeigen, dass der Zusammenhang zwischen Kaffeekonsum und Herz-Kreislauf-Risiko vom CYP1A2-Genotyp abhängt – sogenannte ‚schnelle‘ und ‚langsame‘ Koffein-Metabolisierer. Allerdings ist die Evidenz für direkte Auswirkungen auf die Langlebigkeit schwach. Die meisten Effekte sind klein und werden durch Lebensstil, Rauchen und andere Faktoren überlagert. Ein DNA-Test kann Ihren Genotyp bestimmen, aber daraus allein lässt sich keine Vorhersage für die Lebenserwartung ableiten. Die Aussage ‚Kaffee ist gut/schlecht für Sie basierend auf Ihrem CYP1A2-Gen‘ ist eine Vereinfachung. Die Forschung zeigt moderate Zusammenhänge für Herz-Kreislauf-Ereignisse, aber nicht für Langlebigkeit. Nutzen Sie das Ergebnis als Hinweis, nicht als Schicksal. Sicherheitshinweis: Bei bekannten Herzproblemen oder Schwangerschaft ist Koffeinkonsum generell zu begrenzen.","area":"gesundheit","canonical_id":"gesundheit:canonical-a00d08c582d1b44a3d9dfd03","id":"public-01ddee0344f40b08e735f1a6","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: CYP1A2 und longevity","score":30.29602434,"snippet":"CYP1A2 ist ein Gen, das den Koffeinabbau in der Leber steuert. Der Mythos besagt, dass die Genvariante bestimmt, ob Kaffee die Lebenserwartung verlängert oder verkürzt. Die Fakten: Es gibt tatsächlich Studien, die zeigen, dass der Zusammenhang zwischen Kaffeekonsum und Herz-Kreislauf-Risiko vom CYP1A2-Genotyp abhängt – sogenannte ‚schnelle‘ und ‚langsame‘ Koffein-Metabolisierer. Allerdings ist die Evidenz für direkte Auswirkungen auf die Langlebigkeit schwach. Die meisten Effekte sind klein und werden durch Lebensstil, Rauchen und andere Faktoren überlagert. Ein DNA-Test kann Ihren Genotyp bestimmen, aber daraus allein lässt sich keine Vorhersage für die Lebenserwartung ableiten. Die Aussage","sources":[],"title":"Myths vs Facts: CYP1A2 und longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-01ddee0344f40b08e735f1a6/myths-vs-facts-cyp1a2-und-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 is an enzyme involved in metabolizing caffeine and some drugs. Common variants (e.g., rs762551) are labeled 'fast' or 'slow' metabolizers. Claims that 'slow' metabolizers have higher cardiovascular risk and thus shorter lifespan are widespread but poorly supported. While some association studies link CYP1A2 variants to caffeine intake and blood pressure, direct evidence for an effect on longevity is lacking. Longevity is a complex trait influenced by many genes, lifestyle, and environment; a single CYP1A2 variant has at most a minor, context-dependent role. Marketing that positions CYP1A2 as a 'longevity gene' overstates the science. Consumer DNA tests can indicate predisposition but are not diagnostic. Individuals can adjust caffeine consumption based on personal tolerance without genetic testing. The evidence level is mechanistic/unclear, not human-strong.","area":"gesundheit","canonical_id":"gesundheit:canonical-97da4b4df983c321d97eb7a1","id":"public-aaface274ec3f489a1be450a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP1A2 and Langlebigkeit","score":30.18382808,"snippet":"CYP1A2 is an enzyme involved in metabolizing caffeine and some drugs. Common variants (e.g., rs762551) are labeled 'fast' or 'slow' metabolizers. Claims that 'slow' metabolizers have higher cardiovascular risk and thus shorter lifespan are widespread but poorly supported. While some association studies link CYP1A2 variants to caffeine intake and blood pressure, direct evidence for an effect on longevity is lacking. Longevity is a complex trait influenced by many genes, lifestyle, and environment; a single CYP1A2 variant has at most a minor, context-dependent role. Marketing that positions CYP1A2 as a 'longevity gene' overstates the science. Consumer DNA tests can indicate predisposition but ","sources":[],"title":"Myths vs facts: CYP1A2 and Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-aaface274ec3f489a1be450a/myths-vs-facts-cyp1a2-and-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The claim that a DNA metabolism test can provide precise, clinically actionable dietary recommendations to extend lifespan is largely a myth. The facts: a few validated genetic variants (e.g., MCM6 for lactase persistence, CYP1A2 for caffeine metabolism, MTHFR C677T for folate metabolism) have reproducible but usually small effects on nutrient handling. Most commercial tests, however, sell markers with weak or absent evidence—such as those for 'optimal' macronutrient ratios or gluten sensitivity. The association between FADS1 variants (rs174546) and omega-3 needs, for example, is only detectable at the population level (GWAS, small effect) and is not clinically actionable alone. A blood test for actual omega-3 levels is more informative. Similarly, homocysteine is a moderate risk marker for cardiovascular disease; B-vitamins lower it, but whether this extends lifespan in healthy individuals is unproven. Longevity is multifactorial (epigenetics, lifestyle, environment)—a DNA test alone cannot provide a reliable 'longevity diet'. Marketing claims greatly overstate the evidence. Bottom line: these tests can offer interesting background information but not evidence-based life extension.","area":"gesundheit","canonical_id":"gesundheit:canonical-0696fc79be2e061b094efd7c","id":"public-a4cdd5e02954809d4692bb93","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: DNA Stoffwechseltest and longevity","score":28.22598983,"snippet":"The claim that a DNA metabolism test can provide precise, clinically actionable dietary recommendations to extend lifespan is largely a myth. The facts: a few validated genetic variants (e.g., MCM6 for lactase persistence, CYP1A2 for caffeine metabolism, MTHFR C677T for folate metabolism) have reproducible but usually small effects on nutrient handling. Most commercial tests, however, sell markers with weak or absent evidence—such as those for 'optimal' macronutrient ratios or gluten sensitivity. The association between FADS1 variants (rs174546) and omega-3 needs, for example, is only detectable at the population level (GWAS, small effect) and is not clinically actionable alone. A blood test","sources":[],"title":"Myths vs facts: DNA Stoffwechseltest and longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a4cdd5e02954809d4692bb93/myths-vs-facts-dna-stoffwechseltest-and-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}